Mr. Shashi Bhushan is a distinguished entrepreneur, innovator, and venture capitalist who has made significant developments in the business world. His entrepreneurial spirit, coupled with his innovative mindset, has led him to establish multiple successful companies, each making a unique impact in their respective industries.
As the Chairman of Stellar Innovations, a leading insurance company, and Mediomix, a trailblazer in the healthcare industry, Mr. Bhushan has demonstrated exceptional leadership skills. His strategic vision and guidance have been instrumental in propelling these companies to new heights of success.
At Mediomix, his innovative approach has revolutionized healthcare delivery,making quality healthcare accessible and affordable by using the predictive model through the AI and ML. His relentless pursuit of excellence and commitment to innovation has positioned Mediomix as a game-changer in the healthcare sector. Mr. Bhushan vision is to provide the Quality health care services in short time with the affordable pricing to help the human society.
Chief Executive Officer
Binoy Audwin D’Cruz is an accomplished executive with over 25 years of leadership experience in data, analytics, and digital transformation. As CEO of Mediomix, he is driving the company’s mission to advance genomics as a cornerstone of preventive healthcare, precision medicine, and applied human performance.
Throughout his career, Binoy has led global enterprises of over 4,000 professionals across six countries, delivering measurable impact—10x business growth, 70% cost optimization, and significant improvements in operational excellence. His expertise lies in building large-scale, end-to-end data ecosystems and translating complex science into practical, high-value solutions.
At Mediomix, Binoy is applying this expertise to establish cutting-edge genomic testing, data harmonization, and bioinformatics platforms that integrate clinical rigor with consumer accessibility. His leadership is focused on scaling genomic science into mainstream healthcare, fostering global collaborations, and positioning Mediomix at the forefront of personalized medicine and translational genomics.
Binoy holds a Post Graduate Certification in Data Science & Artificial Intelligence and is a Certified Chief Technology Officer (CTO) from the Indian School of Business, credentials that reflect his commitment to applying advanced technology in transforming healthcare.
Chief Finance Officer
Ravindra Nag, a Chartered Accountant with two decades of experience in financial management, excels in strategizing and implementing growth-driven financial plans.
At Mediomix, his leadership and commitment to financial excellence have been crucial in achieving sustainable growth and financial stability. His profound knowledge in corporate governance ensures the company’s adherence to best practices. Under his guidance, Mediomix has consistently met its financial targets and positioned itself as a market leader.
Chief Information Officer
Manjunath Narasimhan is a visionary leader with a strong focus on customer-first strategies and deeply committed to leveraging cutting-edge technologies. His extensive experience in technology and business operations guides our overall operations, product development, and customer satisfaction at Mediomix.
Manjunath’s leadership has been key in driving Mediomix’s digital transformation, ensuring a robust and secure technology infrastructure. His expertise has led to innovative solutions that significantly enhance our customer value.
Director
Ganga Narasimhan, co-founder of Mediomix Diagnosis and Bioresearch Pvt. Ltd., holds an MS in Molecular Biology from Georgetown University.
Her enthusiasm for genetics combined with her breadth of industry knowledge led her from scientist to entrepreneur. Her vision and leadership are essential to the success of Mediomix’s growth strategy. She continues to motivate her team to attain success and make important contributions to the field with her creative approach and commitment to advance bioresearch. Mediomix is ready to transform the bioresearch sector under her leadership.